Asymmetric Organocatalysts

Eder et al. and Hajos et al. separately reported an intramolecular asymmetric aldol reaction which employed proline as the only asymmetric catalyst at the beginning of the 1970s.1) This reaction was considered to be a special case at that time. Later in 2000, List et al. reported an intermolecular asymmetric aldol reaction which used proline as a catalyst.2) List’s report received broad attention and served as a trigger to make research active for asymmetric organic catalysts. Therefore, varieties of asymmetric organic catalysts have been developed and the research has been applied to many areas.3) The proline derivative 1, having the heterocyclic ring was developed by Nakamura et al. It shows high TON as an asymmetric catalyst for obtaining a chiral aldol adduct.4)

Compared with conventional metal complex catalysts, asymmetric organic catalysts are considered to be environmentally friendly and are expected to be further developed because they are stable, easy to handle and free of harmful metals.

Prolines and its analogs

Other Amino Acids

Cinchona Alkaloids

Oxazaborolidines

Chiral Phosphoric Acids

Chiral Diols

Chiral Phase-Transfer Catalysts

Other Catalysts

Prolines and its analogs

D2365 D2365 D2735 D2735 A1301 A1301
A0945 A0945 A1043 A1043 B3440 B3440
D3803 D3803 D3804 D3804 D3185 D3185
D3186 D3186 H0768 H0768 H0784 H0784
I0395 I0395 M1161 M1161 M1169 M1169
M1097 M1097 M1183 M1183 M2077 M2077
M1995 M1995 O0370 O0370 P1404 P1404
P1830 P1830 P0481 P0481 P0994 P0994
P1241 P1241 P1925 P1925 P1784 P1784
T2637 T2637 T0219 T0219
D2365 (R)-(+)-alpha,alpha-Diphenyl-2-pyrrolidinemethanol
D2735 (S)-(-)-alpha,alpha-Diphenyl-2-pyrrolidinemethanol
A1301 (S)-(-)-2-Aminomethyl-1-ethylpyrrolidine
A0945 (S)-(+)-2-(Anilinomethyl)pyrrolidine
A1043 L-Azetidine-2-carboxylic Acid [Antagonist of L-Proline]
B3440 trans-4-(tert-Butyldiphenylsilyloxy)-L-proline
D3803 (R)-(+)-2-(Diphenylmethyl)pyrrolidine
D3804 (S)-(-)-2-(Diphenylmethyl)pyrrolidine
D3185 (2R,5R)-2,5-Diphenylpyrrolidine
D3186 (2S,5S)-2,5-Diphenylpyrrolidine
H0768 (S)-(+)-2-[Hydroxy(diphenyl)methyl]-1-methylpyrrolidine
H0784 (R)-(-)-2-[Hydroxy(diphenyl)methyl]-1-methylpyrrolidine
I0395 (S)-(-)-Indoline-2-carboxylic Acid
M1161 (S)-2-(Methoxymethyl)pyrrolidine
M1169 (R)-2-(Methoxymethyl)pyrrolidine
M1097 (S)-(-)-1-Methyl-2-(1-naphthylaminomethyl)pyrrolidine
M1183 (S)-(-)-1-Methyl-2-(1-piperidinomethyl)pyrrolidine
M2077 alpha-Methyl-L-proline
M1995 (S)-2-[(1-Methyl-2-pyrrolidinyl)methyl]isoindoline Dihydrochloride
O0370 (2S,3aS,7aS)-Octahydro-1H-indole-2-carboxylic Acid
P1404 L-Pipecolic Acid
P1830 D-Pipecolic Acid
P0481 L-Proline
P0994 D-Proline
P1241 (S)-(+)-1-(2-Pyrrolidinylmethyl)pyrrolidine
P1925 (R)-(-)-1-(2-Pyrrolidinylmethyl)pyrrolidine
P1784 (S)-5-(Pyrrolidin-2-yl)-1H-tetrazole
T2637 N-(2-Thiophenesulfonyl)-L-prolinamide Trifluoroacetate
T0219 L-Thioproline

Other Amino Acids

A0177 A0177 A0179 A0179 B3398 B3398
T0228 T0228 T0230 T0230 T0539 T0539
T0541 T0541
A0177 D-Alanine
A0179 L-Alanine
B3398 O-tert-Butyl-L-threonine
T0228 D-(+)-Threonine
T0230 L-(-)-Threonine
T0539 D-Tryptophan
T0541 L-Tryptophan

Cinchona Alkaloids

B1683 B1683 B1689 B1689 B1684 B1684
B1685 B1685 C0347 C0347 C0348 C0348
C0349 C0349 C0350 C0350 C0351 C0351
H0752 H0752 I0728 I0728 Q0076 Q0076
Q0074 Q0074 Q0006 Q0006 Q0010 Q0010
Q0028 Q0028 Q0030 Q0030
B1683 N-Benzylcinchonidinium Chloride [Chiral Phase-Transfer Catalyst]
B1689 N-Benzylcinchoninium Chloride [Chiral Phase-Transfer Catalyst]
B1684 N-Benzylquinidinium Chloride [Chiral Phase-Transfer Catalyst]
B1685 N-Benzylquininium Chloride [Chiral Phase-Transfer Catalyst]
C0347 Cinchonidine
C0348 Cinchonidine Dihydrochloride
C0349 Cinchonidine Sulfate Dihydrate
C0350 Cinchonine
C0351 Cinchonine Hydrochloride Hydrate
H0752 Hydroquinidine Hydrochloride
I0728 beta-Isocupreidine
Q0076 Quincoridine
Q0074 Quincorine
Q0006 Quinidine
Q0010 Quinidine Sulfate Dihydrate
Q0028 Quinine
Q0030 Quinine Hydrochloride Dihydrate

Oxazaborolidines

D2130 D2130 D2131 D2131
D2130 (R)-5,5-Diphenyl-2-methyl-3,4-propano-1,3,2-oxazaborolidine
D2131 (S)-5,5-Diphenyl-2-methyl-3,4-propano-1,3,2-oxazaborolidine

Chiral Phosphoric Acids

B1143 B1143 B1144 B1144
B1143 (R)-(-)-1,1'-Binaphthyl-2,2'-diyl Hydrogen Phosphate
B1144 (S)-(+)-1,1'-Binaphthyl-2,2'-diyl Hydrogen Phosphate

Chiral Diols

B1100 B1100 B1142 B1142 B1614 B1614
B2048 B2048 B1615 B1615
B1100 (S)-(-)-1,1'-Bi-2-naphthol
B1142 (R)-(+)-1,1'-Bi-2-naphthol
B1614 (-)-4,5-Bis[hydroxy(diphenyl)methyl]-2,2-dimethyl-1,3-dioxolane
B2048 (+)-4,5-Bis[hydroxy(diphenyl)methyl]-2,2-dimethyl-1,3-dioxolane
B1615 (+)-4,5-Bis[hydroxy(diphenyl)methyl]-2-methyl-2-phenyl-1,3-dioxolane

Chiral Phase-Transfer Catalysts

B1683 B1683 B1689 B1689 B1684 B1684
B1685 B1685 D3475 D3475 D3476 D3476
B1683 N-Benzylcinchonidinium Chloride [Chiral Phase-Transfer Catalyst]
B1689 N-Benzylcinchoninium Chloride [Chiral Phase-Transfer Catalyst]
B1684 N-Benzylquinidinium Chloride [Chiral Phase-Transfer Catalyst]
B1685 N-Benzylquininium Chloride [Chiral Phase-Transfer Catalyst]
D3475 6,10-Dibenzyl-N,N'-dimethyl-N,N,N',N'-tetrakis(4-methylbenzyl)-1,4-dioxaspiro[4.5]decane-(2R,3R)-diylbis(methylammonium) Tetrafluoroborate [=(R,R)-TaDiAS-2nd]
D3476 6,10-Dibenzyl-N,N'-dimethyl-N,N,N',N'-tetrakis(4-methylbenzyl)-1,4-dioxaspiro[4.5]decane-(2S,3S)-diylbis(methylammonium) Tetrafluoroborate [=(S,S)-TaDiAS-2nd]

Other Catalysts

B3296 B3296 B3549 B3549 D3983 D3983
D3984 D3984 L0137 L0137 T1215 T1215
B3296 (+)-Benzotetramisole
B3549 (-)-Benzotetramisole
D3983 (+)-(5aR,10bS)-5a,10b-Dihydro-2-(2,4,6-trimethylphenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Chloride Monohydrate
D3984 (-)-(5aS,10bR)-5a,10b-Dihydro-2-(2,4,6-trimethylphenyl)-4H,6H-indeno[2,1-b][1,2,4]triazolo[4,3-d][1,4]oxazinium Chloride Monohydrate
L0137 L-(+)-Leucinol
T1215 Levamisole Hydrochloride

Literature

1) U. Eder, G. Sauer, R. Wiechert, Angew. Chem. Int. Ed. Engl., 1971, 10, 496 [DOI]; Z. G. Hajos, D. R. Parrish, J. Org. Chem., 1974, 39, 1615 [DOI] .
2) B. List, R. A. Lerner, C. F. Barbas III, J. Am. Chem. Soc., 2000, 122, 2395 [DOI].
3) Review: Acc. Chem. Res., 2004, 37(8), 487-631 [DOI], “ Asymmetric Organocatalysis” (special edition); H. Pellissier, Tetrahedron, 2007, 63, 9267 [DOI].
4) S. Nakamura, N. Hara, H. Nakashima, K. Kubo, N. Shibata, T. Toru, Chem. Eur. J., 2008, 14, 8079 [DOI].


90ac4m0000001xi1